Target intelligence / Profile preview

Plasmodium falciparum secretory and trafficking pathway

Molecular classification
Other
01

Overview

The Plasmodium falciparum secretory and trafficking pathway is a specialized system used by the malaria parasite to transport proteins from its cytoplasm to various internal organelles and into the host erythrocyte. This pathway includes the endoplasmic reticulum (ER), Golgi apparatus, and unique structures such as the apicoplast and the Plasmodium Translocon of Exported Proteins (PTEX) located at the parasitophorous vacuole membrane (PVM) (Deponte, 2012, PMID: 22531113; Elsworth et al., 2014, PMID: 25043010). It is vital for the parasite's ability to remodel the host cell, acquire nutrients, and evade the host immune system by exporting virulence factors like PfEMP1 (Cooke et al., 2004, PMID: 15145198). Key enzymes within this pathway, such as Plasmepsin V, which cleaves the Plasmodium Export Element (PEXEL) motif, are essential for the maturation of exported proteins (Boddey et al., 2010, PMID: 20130577). Drugs targeting this pathway, such as Brefeldin A or experimental Plasmepsin V inhibitors like WEHI-916, disrupt these critical transport processes, leading to parasite death (Sleebs et al., 2014, PMID: 24991914). Given the divergence of some pathway components from human orthologs, it serves as a significant area for the development of novel antimalarials (Heiber et al., 2013, PMID: 23418187).

Other names
Plasmodium falciparum protein export pathwayPlasmodium falciparum endomembrane systemPf secretory pathwayPf trafficking pathway
02

Mechanism of action

Inhibition of protein translocation into the endoplasmic reticulum, blockade of PEXEL motif cleavage by Plasmepsin V, disruption of Golgi-mediated vesicle trafficking, or inhibition of the PTEX translocon at the parasitophorous vacuole membrane.

03

Biological functions

Protein traffickingProtein secretionHost cell remodelingOrganelle biogenesisIntracellular transport
04

Disease associations

InfectionMalaria
05

Safety considerations

Host cell toxicityOff-target inhibition of human secretory machineryDrug resistanceComplexity of multi-protein complex targeting
06

Interacting drugs

Brefeldin A

4 more in the full profile.

07

Biomarkers

Histidine-rich protein 2 (HRP2)Parasite lactate dehydrogenase (pLDH)Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1)

Beyond the preview

Go deeper on Plasmodium falciparum secretory and trafficking pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum secretory and trafficking pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call